Literature DB >> 9794116

Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients.

L M Chuang, K C Lee, C N Huang, H P Wu, T Y Tai, B J Lin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794116     DOI: 10.1007/s001250051060

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  -To: Poa NR, Cooper GJS, Edgar PF: Amylin gene promoter mutations predispose to Type 2 diabetes in New Zealand Maori. Diabetologia 46: 574-578.

Authors:  A Novials; A Kistauri; A Chico; R Gomis
Journal:  Diabetologia       Date:  2003-11-05       Impact factor: 10.122

2.  S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin.

Authors:  S Sakagashira; H J Hiddinga; K Tateishi; T Sanke; T Hanabusa; K Nanjo; N L Eberhardt
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 3.  Neuroendocrine hormone amylin in diabetes.

Authors:  Xiao-Xi Zhang; Yan-Hong Pan; Yan-Mei Huang; Hai-Lu Zhao
Journal:  World J Diabetes       Date:  2016-05-10

4.  Polymorphism in intron 2 of islet amyloid polypeptide gene is associated with lower low-density lipoprotein cholesterol in nondiabetic subjects and in type 2 diabetic patients.

Authors:  I Rojas; R Gomis; E Casals; L I Quintó; C Franco; A Novials
Journal:  Endocrine       Date:  2002-11       Impact factor: 3.633

5.  Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies.

Authors:  Yaron Bram; Anat Frydman-Marom; Inbal Yanai; Sharon Gilead; Ronit Shaltiel-Karyo; Nadav Amdursky; Ehud Gazit
Journal:  Sci Rep       Date:  2014-03-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.